Lydia Warburton

6PUBLICATIONS
25CO-AUTHORS
Liquid biopsiesCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 11, 2025
A scoping review of factors influencing the implementation of liquid biopsy for cancer care.

Samran Sheriff, Maree Saba, Romika Patel

|Sep 02, 2021
Intra- and intertumoral heterogeneity of liver metastases in a patient with uveal melanoma revealed by single-cell RNA sequencing.

Weitao Lin, Aaron B Beasley, Nima Mesbah Ardakani

|Dec 19, 2020
The Prognostic Impact of Circulating Tumour DNA in Melanoma Patients Treated with Systemic Therapies-Beyond BRAF Mutant Detection.

Gabriela Marsavela, Peter A Johansson, Michelle R Pereira

|Nov 26, 2020
Circulating Tumour DNA in Advanced Melanoma Patients Ceasing PD1 Inhibition in the Absence of Disease Progression.

Lydia Warburton, Leslie Calapre, Michelle R Pereira

|Oct 17, 2020
Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy.

Gabriela Marsavela, Jenny Lee, Leslie Calapre

|Nov 16, 2019
Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report.

Leslie Calapre, Lydia Warburton, Michael Millward

Pageof 1

Frequent Collaborators

5 joint publications

Elin S Gray

2 joint publications

Gabriela Marsavela

2 joint publications

Leslie Calapre

2 joint publications

Ashleigh C McEvoy